15 reports

RNA Analysis Market

3464 3950 3081

Report Scope: This study offers a global view of the RNA analysis for various applications.This report analyzes and assesses different types of RNA analysis involved, namely microarrays, polymerase chain reaction (PCR), sequencing technologies, and RNAi gene silencing. It also provides information by application,...

  • Molecular Diagnostics
  • RNA
  • World
  • APAC

RNA Based Therapeutic Market by Disease Type (RNA interference (RNAi) and RNA antisense), Application (Genetic Disorders and Auto Immune Disorders) and End User (Research Institutes, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2030 The global RNA based therapeutics market generated...

  • Therapy
  • RNA
  • Antisense Technology
  • Genetic Disorder
  • Autoimmune Disease
  • World
  • APAC

“RNA interference - Pipeline Insight, 2022” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in RNA interference pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • RNA
  • World

INTRODUCTION Small molecule products presently dominate the overall pharmaceutical market, representing around 80% of the total pipeline candidates. In fact, in 2020, the USFDA approved 55 drugs, of which, over 65% were small molecule therapeutics. , It is worth noting that majority of these drugs were conventionally developed...

  • RNA
  • Neurological Disorder
  • Therapy
  • World

23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 Summary 23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 provides in depth analysis on 23S Ribosomal RNA (23S rRNA) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications,...

  • RNA
  • World

16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 Summary 16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 provides in depth analysis on 16S Ribosomal RNA (16S rRNA) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications,...

  • RNA
  • World

Abstract: - Global RNA Interference (RNAi) Market to Reach $55.6 Billion by 2027 - Amid the COVID-19 crisis, the global market for RNA Interference (RNAi) estimated at US$21.2 Billion in the year 2020, is projected to reach a revised size of US$55.6 Billion by 2027, growing at a CAGR of 14.7% over the analysis period...

  • RNA
  • World
  • China
  • United States

RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective This report provides you with a landscape description and analysis of discovery and development of small molecules against RNA as a drug target from an industry perspective as of September...

  • RNA
  • RNAi Technology
  • United States
  • World
  • Drug Approval
  • Diagnostic Imaging Density

The Europe RNA Based Therapeutic Market would witness market growth of 14.9% CAGR during the forecast period (2021-2027). RNA-based therapies have been investigated as a possible treatment option for difficult-to-treat disorders. The therapies are being developed using promising technologies including RNA interference technology (RNAi)...

  • RNA
  • Therapy
  • Europe
  • Germany

The Asia Pacific RNA Based Therapeutic Market would witness market growth of 15.6% CAGR during the forecast period (2021-2027). RNA-based biopharmaceuticals, which include vaccines and treatments, are a relatively new class of medicine. These biopharmaceuticals are preventive medicines that are used to treat a variety of rare and chronic...

  • Therapy
  • Antisense Technology
  • RNA
  • APAC

The North America RNA Based Therapeutic Market would witness market growth of 14.8% CAGR during the forecast period (2021-2027). RNA polymerase synthesizes RNA from template DNA, with messenger RNA (mRNA) serving as a biomolecule that connects DNA expression and protein translation. Both coding and non-coding RNAs have drawn special...

  • RNA
  • Genetic Disorder
  • Marketing Research
  • Therapy
  • Autoimmune Disease
  • Chronic Disease
  • North America
  • United States

Market Overview The RNA-interference (RNAi) market is expected to witness a CAGR of 20.2% during the forecast period. Certain factors that are driving the market growth include the increasing number of applications in molecular diagnostics, particularly in cancer and improving synthetic delivery carriers and chemical modifications...

  • RNA
  • APAC
  • World
  • Europe
  • Cancer Incidence
  • Drug Approval

This study covers the world outlook for antisense and RNA interference (RNAi) therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and...

  • RNA
  • Antisense Technology
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for RNA interference (RNAi) technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • RNA
  • World
  • Gross Domestic Product
  • Disposable Income

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: Datamonitors' Traversa...

  • Drug Development
  • Private Placement
  • Therapy
  • RNA
  • United States
  • Dates Price